Curexo Overview
- Year Founded
-
1992
- Status
-
Public
- Employees
-
103
- Stock Symbol
-
060280
- Investments
-
2
- Share Price
-
$5.04
- (As of Friday Closing)
Curexo General Information
Description
Curexo Inc is a South Korea based company engages in the distribution of medical equipment including Magnetic Resonance Imaging (MRI), endoscopy, and others. It has developed medical devices such as the surgical device for breast cancer and drug delivery technologies.
Contact Information
Website
www.curexo.comCorporate Office
- 3rd, 4th Floor, KR Industrial Building
- 480 Wirye Sunhwan-ro, Songpa-gu
- Seoul, 463-400
- South Korea
Corporate Office
- 3rd, 4th Floor, KR Industrial Building
- 480 Wirye Sunhwan-ro, Songpa-gu
- Seoul, 463-400
- South Korea
Curexo Stock Performance
As of 13-Nov-2026, Curexo’s stock price is $5.04. Its current market cap is $208M with 41.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.04 | $4.98 | $4.63 - $15.52 | $208M | 41.3M | 190K | $0.09 |
Curexo Financials Summary
As of 30-Jun-2026, Curexo has a trailing 12-month revenue of $53.6M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 229,687 | 353,385 | 155,075 | 562,987 |
| Revenue | 53,568 | 52,371 | 40,699 | 55,744 |
| EBITDA | 5,322 | 3,354 | (5,794) | (3,121) |
| Net Income | 3,798 | 1,947 | (6,419) | (3,714) |
| Total Assets | 72,226 | 70,234 | 69,644 | 83,318 |
| Total Debt | 810 | 810 | 1,077 | 1,598 |
Curexo Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Curexo Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Curexo Patents
Curexo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026106154-A1 | Multi-joint robot-assisted gait training system and training method | Pending | 13-Nov-2024 | ||
| EP-4775192-A1 | System for gait training assisted by articulated robot and control method thereof | Pending | 13-Nov-2024 | ||
| WO-2026105969-A1 | System for gait training assisted by articulated robot and control method thereof | Pending | 13-Nov-2024 | ||
| EP-4755365-A1 | Gait rehabilitation robot and training method thereof | Pending | 07-Nov-2024 | ||
| US-20260124093-A1 | Gait rehabilitation robot and training method thereof | Pending | 07-Nov-2024 | A61H1/0262 |
Curexo Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Curexo Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Curexo Investments & Acquisitions (2)
Curexo’s most recent deal was a Later Stage VC with Harmonic Bionics for . The deal was made on 15-Jul-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Harmonic Bionics | 15-Jul-2022 | Later Stage VC | Therapeutic Devices | ||
| Hyundai Heavy Industries (Medical Robotics Business) | 13-Mar-2017 | Merger/Acquisition | Other Hardware |
Curexo ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.37 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Curexo Exits (1)
Curexo’s most recent exit was on 15-Jul-2022 from Harmonic Bionics. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Harmonic Bionics | 15-Jul-2022 | Completed |
|
Curexo FAQs
-
When was Curexo founded?
Curexo was founded in 1992.
-
Where is Curexo headquartered?
Curexo is headquartered in Seoul, South Korea.
-
What is the size of Curexo?
Curexo has 103 total employees.
-
What industry is Curexo in?
Curexo’s primary industry is Surgical Devices.
-
Is Curexo a private or public company?
Curexo is a Public company.
-
What is Curexo’s stock symbol?
The ticker symbol for Curexo is 060280.
-
What is the current stock price of Curexo?
As of 13-Nov-2026 the stock price of Curexo is $5.04.
-
What is the current market cap of Curexo?
The current market capitalization of Curexo is $208M.
-
What is Curexo’s current revenue?
The trailing twelve month revenue for Curexo is $53.6M.
-
What is Curexo’s annual earnings per share (EPS)?
Curexo’s EPS for 12 months was $0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
